SOPHiA GENETICS SA
SOPH
$3.12
$0.051.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 67.17M | 65.17M | 64.49M | 64.94M | 64.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 67.17M | 65.17M | 64.49M | 64.94M | 64.18M |
| Cost of Revenue | 21.43M | 21.24M | 20.75M | 20.59M | 20.56M |
| Gross Profit | 45.74M | 43.94M | 43.73M | 44.35M | 43.62M |
| SG&A Expenses | 75.68M | 76.32M | 77.04M | 78.43M | 81.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -185.00K | -183.00K | -244.00K | -947.00K | -970.00K |
| Total Operating Expenses | 131.02M | 131.74M | 132.53M | 134.16M | 138.45M |
| Operating Income | -63.85M | -66.57M | -68.04M | -69.22M | -74.27M |
| Income Before Tax | -64.76M | -61.27M | -70.78M | -66.00M | -72.29M |
| Income Tax Expenses | 1.41M | 1.22M | 615.00K | 784.00K | 696.00K |
| Earnings from Continuing Operations | -66.17 | -62.49 | -71.40 | -66.78 | -72.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.17M | -62.49M | -71.40M | -66.78M | -72.99M |
| EBIT | -63.85M | -66.57M | -68.04M | -69.22M | -74.27M |
| EBITDA | -59.79M | -62.24M | -63.73M | -64.53M | -69.05M |
| EPS Basic | -1.00 | -0.95 | -1.09 | -1.02 | -1.12 |
| Normalized Basic EPS | -0.61 | -0.58 | -0.67 | -0.63 | -0.70 |
| EPS Diluted | -1.00 | -0.95 | -1.09 | -1.02 | -1.12 |
| Normalized Diluted EPS | -0.61 | -0.58 | -0.67 | -0.63 | -0.70 |
| Average Basic Shares Outstanding | 265.05M | 263.51M | 262.64M | 261.32M | 259.91M |
| Average Diluted Shares Outstanding | 265.05M | 263.51M | 262.64M | 261.32M | 259.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |